
SK609 HCl
CAS No. 1092797-77-7
SK609 HCl( —— )
Catalog No. M34027 CAS No. 1092797-77-7
SK609 HCl (SK609 hydrochloride) is a dopamine D3 receptor (D3R) selective agonist that inhibits norepinephrine transporter proteins and can be used to study Parkinson's disease and cognitive disorders.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 122 | Get Quote |
![]() ![]() |
5MG | 186 | Get Quote |
![]() ![]() |
10MG | 274 | Get Quote |
![]() ![]() |
25MG | 453 | Get Quote |
![]() ![]() |
50MG | 632 | Get Quote |
![]() ![]() |
100MG | 875 | Get Quote |
![]() ![]() |
500MG | 1737 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSK609 HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionSK609 HCl (SK609 hydrochloride) is a dopamine D3 receptor (D3R) selective agonist that inhibits norepinephrine transporter proteins and can be used to study Parkinson's disease and cognitive disorders.
-
DescriptionSK609 hydrochloride is a dopamine D3 receptor (D3R) selective agonist with an EC50 of 1109 nM. SK609 hydrochloride has the potential for parkinson research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine Receptor | Norepinephrine
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1092797-77-7
-
Formula Weight220.14
-
Molecular FormulaC10H15Cl2N
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.ClC=1C=CC=CC1CCC(N)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
NGD 94-1
NGD 94-1 is a selective D4 receptor antagonist with an affinity of 3 nM for the D4 receptor and greater than 2 pM for the D1, D2, D3, and D5 receptors.
-
GBR-12935
GBR 12935 induced increase in the extracellular levels of dopamine to basal levels.
-
ONC206
ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??